Piqray

Active Ingredient(s): Alpelisib
FDA Approved: * May 24, 2019
Pharm Company: * NOVARTIS PHARMS CORP
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Piqray Overview

Alpelisib (INN; development code BYL719; brand name Piqray) is a medication used to treat certain types of breast cancer.[1] It is used together with fulvestrant.[1] It is taken by mouth.[1] Common side effects include high blood sugar, kidney problems, diarrhea, rash, low blood cells, liver problems, pancreatitis, vomiting, and hair loss.[1] It is an alpha-specific PI3K inhibitor.[1][2] It was app...

Read more Piqray Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alpelisib

Recent Piqray Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Alpelisib
  • Tablet: 150mg, 200mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Piqray: (3 results)

Sorted by National Drug Code
  • 0078-0701 Piqray 200 mg Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0708 Piqray 150 mg Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0715 PiqrayPiqray Kit by Novartis Pharmaceuticals Corporation

Other drugs which contain Alpelisib or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 August 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA